Universal Ibogaine Inc (IBO) - Cash Flow Conversion Efficiency

Latest as of April 2025: -0.405x

Based on the latest financial reports, Universal Ibogaine Inc (IBO) has a cash flow conversion efficiency ratio of -0.405x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-110.36K ≈ $-79.84K USD) by net assets (CA$272.17K ≈ $196.89K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Universal Ibogaine Inc balance sheet quality to measure how much of total assets are equity-financed.

Universal Ibogaine Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how Universal Ibogaine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IBO total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Universal Ibogaine Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Universal Ibogaine Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Magle Chemoswed Holding Ab ST:MAGLE	-0.006x
BEACN Wizardry & Magic Inc V:BECN	2.904x
RIDGESTONE MINING INC. F:4U50	0.006x
Starbox Group Holdings Ltd. Ordinary Shares NASDAQ:STBX	-0.001x
Handal Resources Bhd KLSE:7253	0.099x
Bit Origin Ltd NASDAQ:BTOG	0.201x
Altai Resources Inc. V:ATI	-0.051x
Imalliance SA PA:MLIML	N/A

Annual Cash Flow Conversion Efficiency for Universal Ibogaine Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of Universal Ibogaine Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Universal Ibogaine Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-07-31	CA$991.11K ≈ $716.95K	CA$-838.61K ≈ $-606.64K	-0.846x	-35.07%
2023-07-31	CA$1.75 Million ≈ $1.27 Million	CA$-1.10 Million ≈ $-793.82K	-0.626x	+43.00%
2022-07-31	CA$3.94 Million ≈ $2.85 Million	CA$-4.33 Million ≈ $-3.13 Million	-1.099x	-100.15%
2021-07-31	CA$-4.46K ≈ $-3.22K	CA$-3.25 Million ≈ $-2.35 Million	729.129x	+3068.20%
2020-07-31	CA$94.89K ≈ $68.64K	CA$-2.33 Million ≈ $-1.69 Million	-24.565x	-433.93%
2019-07-31	CA$197.12K ≈ $142.59K	CA$-906.88K ≈ $-656.02K	-4.601x	-324.00%
2018-07-31	CA$295.22K ≈ $213.56K	CA$-320.34K ≈ $-231.73K	-1.085x	--

About Universal Ibogaine Inc

V:IBO Canada Biotechnology

Market Cap

$1.13 Million

CA$1.56 Million CAD

Market Cap Rank

#30488 Global

#1564 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$0.24